Mortality Reduction After Oral Azithromycin: Morbidity Study

PHASE4CompletedINTERVENTIONAL
Enrollment

72,000

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 27, 2020

Study Completion Date

August 27, 2020

Conditions
Childhood Mortality
Interventions
DRUG

Azithromycin

Biannual mass oral azithromycin to children

DRUG

Placebo

Biannual mass oral placebo to children

Trial Locations (6)

21205

Johns Hopkins University, Baltimore

94143-0944

UCSF Proctor Foundation, San Francisco

Unknown

College of Medicine at the University of Malawi, Blantyre, Blantyre

The Carter Center, Niger, Niamey

Kongwa Trachoma Project, Kongwa

London School of Hygiene & Tropical Medicine, London

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

London School of Hygiene and Tropical Medicine

OTHER

lead

University of California, San Francisco

OTHER

NCT02048007 - Mortality Reduction After Oral Azithromycin: Morbidity Study | Biotech Hunter | Biotech Hunter